68 Ga-FAPI-04: A Powerful Tool for Detecting Subcentimeter Metastases of Intrahepatic Cholangiocarcinoma
- Yu Sun 1, Jianjun Jiang , Qingyuan Meng , Weilun Wang , Jun Zhao
- 1Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
- 0Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Gallium-68 FAPI PET/CT imaging offers superior detection of small intrahepatic cholangiocarcinoma metastases compared to standard FDG PET/CT and MRI. This advanced imaging technique improves the identification of recurrent disease, aiding in patient management.
Area Of Science
- Oncology
- Nuclear Medicine
- Radiology
Background
- Intrahepatic cholangiocarcinoma (ICC) is a rare but aggressive biliary tract cancer.
- Recurrence, particularly with small subcentimeter liver metastases, poses a diagnostic challenge.
- Current imaging modalities may have limitations in detecting minimal residual disease.
Purpose Of The Study
- To evaluate the diagnostic performance of 68Ga-FAPI-04 PET/CT in detecting subcentimeter liver metastases from intrahepatic cholangiocarcinoma.
- To compare the sensitivity of 68Ga-FAPI-04 PET/CT with 18F-FDG PET/CT and conventional MRI.
Main Methods
- A case study involving a 53-year-old woman with a history of resected ICC.
- Comparison of imaging findings from 18F-FDG PET/CT, 68Ga-FAPI-04 PET/CT, and contrast-enhanced MRI.
- Assessment of lesion detection rates and tracer uptake in identified metastases.
Main Results
- 18F-FDG PET/CT failed to detect any FDG-avid lesions.
- 68Ga-FAPI-04 PET/CT successfully identified three subcentimeter liver metastases with high FAPI uptake.
- Conventional and contrast-enhanced MRI detected only 1-2 lesions, missing at least one metastasis identified by 68Ga-FAPI-04 PET/CT.
Conclusions
- 68Ga-FAPI-04 PET/CT demonstrates superior sensitivity for detecting small, subcentimeter liver metastases of intrahepatic cholangiocarcinoma.
- Fibroblast Activation Protein (FAP) targeted imaging offers a significant advantage over 18F-FDG PET/CT and MRI in this clinical scenario.
- 68Ga-FAPI-04 PET/CT may improve the early detection and management of recurrent ICC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

